Shares of BiomX Inc. (NYSEAMERICAN:PHGE – Get Free Report) fell 1.5% during trading on Friday . The stock traded as low as $0.91 and last traded at $0.92. 28,858 shares traded hands during trading, a decline of 74% from the average session volume of 111,444 shares. The stock had previously closed at $0.93.
BiomX Trading Down 1.5 %
The stock has a market cap of $16.44 million, a P/E ratio of -1.51 and a beta of 1.30. The company has a debt-to-equity ratio of 1.75, a quick ratio of 4.80 and a current ratio of 4.80.
BiomX (NYSEAMERICAN:PHGE – Get Free Report) last released its quarterly earnings results on Wednesday, August 14th. The company reported $0.70 EPS for the quarter, beating the consensus estimate of ($1.20) by $1.90. As a group, equities research analysts predict that BiomX Inc. will post -2.7 EPS for the current year.
About BiomX
BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).
Featured Articles
- Five stocks we like better than BiomX
- Best Aerospace Stocks Investing
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- Airline Stocks – Top Airline Stocks to Buy Now
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- How to Calculate Options Profits
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.
